Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
The Revised National TB Control Programme (RNTCP), based on the internationally recommended Directly Observed Treatment Short-course (DOTS) strategy, was launched in 1997 expanded across the country in a phased manner with support from World Bank and other development partners.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
A decentralized system of disease surveillance for timely and effective public health action with a focus on functional integration of surveillance components of various vertical programmes.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
The Revised National TB Control Programme (RNTCP), based on the internationally recommended Directly Observed Treatment Short-course (DOTS) strategy, was launched in 1997 expanded across the country in a phased manner with support from World Bank and other development partners.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
A decentralized system of disease surveillance for timely and effective public health action with a focus on functional integration of surveillance components of various vertical programmes.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
1. UNIVERSAL IMMUNISATION PROGRAM
PRESENTED BY:
Rahul Kumar
Roll No. 31
PRESENTED TO:
Dr. Priyadarshini Tiwari
Faculty of Social Science
M.A. ( Integrated Rural Development and Management)
2. 1
INTRODUCTI
ON
• Universal Immunization Programme (UIP),
started in India in 1985. Ministry of Health
& Family Welfare provides several
vaccines to infants, children & pregnant
women through UIP. Immunization is a
process through which a person is made
immune to an infectious disease.
• Universal Immunization Programme (UIP) is
one of the largest public health
programmes targeting close of 2.67 crore
newborns and 2.9 crore pregnant women
annually.
3. 2
• Sub-nationally against 3 diseases Rotavirus diarrhoea, Pneumococcal Pneumonia
and Japanese Encephalitis; of which Rotavirus vaccine and Pneumococcal
Conjugate vaccine are in process of expansion while JE vaccine is provided only
in endemic districts.
• A child is said to be fully immunized if child receives all due vaccine as per
national immunization schedule within 1st year age of child.
• The two major milestones of UIP have been the elimination of polio in 2014 and
maternal and neonatal tetanus elimination in 2015.
• It is one of the most cost-effective public health interventions and largely
responsible for reduction of vaccine preventable under-5 mortality rate.
• Under UIP, immunization is providing free of cost against 12 vaccine preventable
diseases: Nationally against 9 diseases Diphtheria, Pertussis, Tetanus Polio,
Measles, Rubella, severe form of Childhood Tuberculosis, Hepatitis B and
Meningitis & Pneumonia caused by Hemophilus Influenza type B
4. 3
HISTO
RY
• Under Global Smallpox Eradication Programme, it was experienced that
immunization is the most powerful and cost effective weapon for the
prevention and control and even eradication of a disease.
• May 1974, WHO officially launched a global immunization programme,
known as Expanded Programme of Immunization for the prevention and
control of six major, killer disease of children, namely tuberculosis,
diphtheria, pertussis, tetanus, poliomyelitis, and measles, all over the world
by the year 2000.
• EPI was launched in India in January 1978.
• Government of India launched same program with same schedule on 1st
January 1978 with the same objectives of reducing child morbidity and
mortality rates and to achieve self sufficiency in the production of
vaccines.
• WHO launched a social target of achieving Health for all by 2000 AD.
5. 4
• The Programme is now called Universal Child Immunization, 1990- that's
the name given to a declaration sponsored by UNICEF as part of the
'United Nations' 40th anniversary in October 1985. It is aimed at adding
impetus to the global programme of EPI.
• The Indian version, the 'Universal Immunization Programme was launched
on November 19, 1985 and was dedicated to the memory of Smt. Indira
Gandhi.
• The National Health Policy was aimed at achieving universal immunization
coverage of the eligible population by 1990. Impetus was added to the
existing program by shifting from under 5 to under 1 year of age and the
quality of services was also improved.
• It was recommended to give 1st dose of TT to the pregnant mother in the
first contact and 2nd dose after 1 month and BCG and OPV to the new
born as early as at birth.
• During 1992, immunization program become a component of Child
Survival and Safe Motherhood (CSSM) program. It was recommended to
cover 100% among infant also.
6. 5
• In 1995, Pulse Polio Immunization Programme was launched as a strategy to
eradicate poliomyelitis. In 1997, immunization activities have been important
component of National Reproductive and Child Health Programme.
• In 2005, immunization schedule was revised incorporating Hepatitis vaccine,
2 doses of JE vaccine in selected endemic district, 1st during 9-12 months
and 2nd during 16-24 months and 2 doses of Measles vaccine, 1st dose
during 9-12 months and 2nd dose during 16-24 months, under National Rural
Health Mission (NRHM).
• In 2012, GOI declared 2012 as the "Year of Intensification of "Routine
Immunization".
• In 2013, GOI along with other S-E Asia regions, declared commitment
towards measles elimination and congenital Rubella syndrome control by
2020.
• In 2014, India was certified as "Polio free country". To strengthen routine
immunization, Government of India has planned the State Programme
Implementation Plan (PIP) part C.
7. 6
OBJECTIVE
S
The stated objectives of UIP are:
• To rapidly increase immunization coverage.
• To improve the quality of services.
• To establish a reliable cold chain system to the health facility level.
• Monitoring of performance.
• To achieve self-sufficiency in vaccine production.
8. 7
COMPONE
NTS
• Strategy and policy:
National Health Policy is directed towards achieving an acceptable,
affordable and sustainable standard of health through an appropriate
health system. Provision of universal immunization of children against
vaccine preventable diseases is one of the major goals under this policy.
The National Vaccine Policy also guides decision making in order to
develop a long term plan to strengthen the UIP.
• Cold Chain System, Vaccines and Logistics:
Cold Chain is a system of storing and transporting vaccine at the
recommended temperature range from the point of manufacture to point
of use.
9. 8
• The Injection safety and waste disposal:
A large number of injection procedures are undertaken in lakhs of vaccination
sessions across the country every year. Unsafe injection practices can harm the
recipient of the injection, the health worker and the community resulting in
potentially life threatening infections such as HIV/AIDS, Hepatitis B and C, etc.
Disposal of immunization waste is strictly as per Central Pollution Control Board
(CPCB) guidelines for biomedical waste disposal.
• Adverse Event Following Immunization (AEFI) Surveillance System :
As a part of the process to strengthen AEFI surveillance in India, an online reporting
system called Surveillance and Action for Events Following Vaccination (SAFEVAC)
has been developed and implemented in a phase-wise manner since May 2019.
Since January 2020, all states and districts are reporting serious and severe AEFI
through SAFEVAC. SAFEVAC promotes real-time reporting of serious and severe
AEFIs, bringing in more efficiency and reduction of loss of data during transmission
from district to state/national levels.
10. 9
• Strategic communication:
Strategic Communication refers to policy-making and guidance for consistent
information activity through coherent messaging. The issue of media advocacy,
proactive planning and effective media response is emerging as one of the key
elements of strategic communication support to achieving f Routine Immunization
coverage in the country.
• Immunization Training:
The Immunization Programme runs due to the coordinated efforts of different cadres
of health staff working in the states of different levels( States, districts, PHCs and
CHCs). The objective is to motive and strengthen the capacity of frontline workers to
reduce dropouts and left outs and improve the quality of services.
• Monitoring and evaluation:
Universal Immunization Program has a set of indicators to monitor progress under
different components of the program and evaluate the coverage of immunization
amongst the target population. In the country, UIP performs monitoring and
evaluation at three levels.
12. 11
Age Vaccine Given
5-6 years DPT-Booster-2
10 years Tetanus & adult Diphtheria (Td)
16 years Tetanus & adult Diphtheria (Td)
Pregnant Mother Td1, 2 or Td Booster**
NATIONAL IMMUNIZATION
SCHEDULE
*One dose if previously vaccinated within 3 years
**JE Vaccine is introduced in selected endemic districts after the campaign
13. 12
• Measles Rubella campaign
The measles-rubella vaccination campaign has been successfully completed in all
States and UTs (it is being carried out in the State of West Bengal). MR campaign
was launched in 2017 and till date the same has been completed in 34 States/UTs,
wherein 32.43 crore children have been vaccinated against the target of 33.07 crore
with a coverage of 98.08%.
• Japanese Encephalitis Campaign
JE vaccine have been introduced under the Routine Immunization in year 2013 to
further protect children from JE. The JE Vaccination campaign covered 321endemic
districts out of 330 identified districts and has covered 170 million children.
• Mission Indradhanush
To strengthen and re-energize the programme and achieve full immunization
coverage for all children and pregnant women at a rapid pace, the Government of
India launched “Mission Indradhanush” in December 2014.
14. 13
• Intensified Mission Indradhanush (IMI)
To further intensify the immunization programme, Prime Minister Shri Narendra Modi
launched the Intensified Mission Indradhanush (IMI) on October 8, 2017. Through
this programme, Government of India aims to reach each and every child up to two
years of age and all those pregnant women who have been left uncovered/missed or
drop out under the routine immunisation programme/UIP. The focus of special drive
was to improve immunisation coverage in select districts and cities to ensure full
immunisation to more than 90%. Total of more than 4.45 crore children and 1.12
crore pregnant women were vaccinated in the intensified campaigns across the
country until 2022.
15. 14
NEW
INITIATIVES
• Introduction of new vaccines
• Rotavirus Vaccine (RVV)
• Measles-Rubella (MR)Vaccine
• Pneumococcal Conjugate Vaccine (PCV)
• Tetanus and adult Diphtheria(Td) vaccine
• Inactivated Polio Vaccine (IPV)
• Improving vaccine coverage
• System strengthening
• Surveillance and Action for Events Following Vaccination (SAFEVAC)
• Surveillance for Vaccine Preventable Disease
• Electronic Vaccine Intelligence Network (eVIN)
• Effective Vaccine Management
• Demand generation activities
• Capacity building
• Strengthening urban immunization
• Efforts for creating awareness and community engagement
16. 15
ACHIEVEMEN
TS
• The biggest achievement of the immunization program is the eradication of
small pox(1977).
• One more significant milestone is that India is free of Poliomyelitis(2014)
caused by Wild Polio Virus (WPV), the last recorded case being in 2011.
• Elimination of maternal and neonatal tetanus in 2016.
• Vaccination has contributed significantly to the decline in the cases and deaths
due to the Vaccine Preventable Diseases (VPDs).